High consumption of
fructose-sweetened beverages has been linked to a high prevalence of chronic
metabolic diseases. We have previously shown that a short course of
fructose supplementation as a liquid
solution induces
glucose intolerance in female rats. In the present work, we characterized the
fructose-driven changes in the liver and the molecular pathways involved. To this end, female rats were supplemented or not with liquid
fructose (10%, w/v) for 7 or 14 days.
Glucose and
pyruvate tolerance tests were performed, and the expression of genes related to
insulin signaling, gluconeogenesis and nutrient sensing pathways was evaluated.
Fructose-supplemented rats showed increased plasma
glucose excursions in
glucose and
pyruvate tolerance tests and reduced hepatic expression of several genes related to
insulin signaling, including
insulin receptor substrate 2 (IRS-2). However, the expression of key gluconeogenic
enzymes,
glucose-6-phosphatase and
phosphoenolpyruvate carboxykinase, was reduced. These effects were caused by an inactivation of hepatic forkhead box O1 (FoxO1) due to an increase in its acetylation state driven by a reduced expression and activity of
sirtuin 1 (
SIRT1). Further contributing to FoxO1 inactivation,
fructose consumption elevated liver expression of the spliced form of X-box-binding-protein-1 as a consequence of an increase in the activity of the
mammalian target of rapamycin 1 and
protein 38-mitogen activated
protein kinase (p38-MAPK). Liquid
fructose affects both
insulin signaling (IRS-2 and FoxO1) and nutrient sensing pathways (
p38-MAPK, mTOR and
SIRT1), thus disrupting hepatic
insulin signaling without increasing the expression of key gluconeogenic
enzymes.